Kusvibiswa kweAmino Acid inoshandiswa kune synthesze protein
Chigadzirwa Chinhu
| NO | Zvigadzirwa | CAT HAPANA | Kiyi yemhando chiratidzo | |||
| Kuchena | Max. Kusachena | Yakazara solvent zvakasara | Kunyorova | |||
| 1 | FMOC-β-ALA-ALA-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 2 | FMOC-D-ALA-D-ALA-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 3 | FMOC-β-ALA-D-ALA-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 4 | FMOC-ARG (PBF) -ARG (PBF) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 5 | FMOC-β-ALA-ARG (PBF) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 6 | FMOC-D-Arg (PBF) -D-Arg (PBF) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 7 | FMOC-β-ALA-D-Arg (PBF) -Oo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 8 | FMOC-HOMARG (PBF) -Homoarg (PBF) -Oo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 9 | FMOC-β-ALA-HOMOARG (PBF) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 10 | FMOC-Asn (TT) -ASN (TT) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 11 | FMOC-β-ALA-Asn (TT) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 12 | FMOC-ASP (OTBU) -ASP (OTBU) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 13 | FMOC-β-ALA-ASP (OTBU) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 14 | FMOC-CIY (TT) -CYS (TT) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 15 | FMOC-β-ALA-CYS (TT) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 16 | FMOC-CIY (ACM) -CYS (ACM) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 17 | FMOC-β-ALA-CYS (ACM) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 18 | FMOC-GLN (TT) -GLN (TT) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 19 | FMOC-β-ALA-GLN (TT) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 20 | FMOC-Glu (OTBU) -Glu (OTBU) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 21 | FMOC-β-ALA-GLLU (OTBU.H.H2O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 22 | FMOC-β-ALA-GLY-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 23 | FMOC-yake (TT) -HIS (TT) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 24 | FMOC-β-ALA-HERE (TT) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 25 | FMOC-ILE-ILE-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 26 | FMOC-β-ALA-ILE-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 27 | FMOC-LEU-LEU-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 28 | FMOC-β-ALA-LEU-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 29 | FMOC-D-LU-D-LU-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 30 | FMOC-β-ALA-D-LEU-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 31 | FMOC-LYS (Boc) -Ls (Boc) -Oo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 32 | FMOC-β-ALA-LYS (Boc) -Oo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 33 | FMOC-LYS (Alloc) -lys (Alloc) -Oo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 34 | FMOC-β-ALA-LYS (Alloc) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 35 | FMOC-MET-MET-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 36 | FMOC-β-ALA-MIST-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 37 | FMOC-Orn (Boc)-Boc (Boc) -Oo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 38 | FMOC-β-ALA-Orn (Boc) -Oo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 39 | FMOC-PHE-PHO-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 40 | FMOC-β-ALA-PHO-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 41 | FMOC-D-PHE-D-PH-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 42 | FMOC-β-ALA-D-PHE-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 43 | FMOC-Pro-Pro-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 44 | FMOC-β-ALA-Pro-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 45 | FMOC-SE (TBU) -ER (TBU) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 46 | FMOC-β-ALA-SER (TBU) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 47 | FMOC-SE (TT) -SE (TT) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 48 | FMOC-β-ALA-SER (TT) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 49 | FMOC-BR (TBU) -TH (TBU) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 50 | FMOC-β-ALA-ALT (TBU) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 51 | FMOC-TRAP (Boc) -TRP (Boc) -Oo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 52 | FMOC-β-ALA-TRP (Boc) -Oo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 53 | FMOC-D-TRP (Boc) -D-TRP (Boc) -Oo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 54 | FMOC-β-ALA-D-TRP (Boc) -Oo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 55 | FMOC-TYR (TBU) -TYR (TBU) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 56 | FMOC-β-ALA-TYR (TBU) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 57 | Fmoc-d-tyr (et) -d-tyr (et) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 58 | FMOC-β-ALA-D-TYR (et) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 59 | FMOC-TYR (Me) -Tyr (ini) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 60 | FMOC-β-ALA-TYR (Me) -Oo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 61 | FMOC -L -L-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 62 | FMOC-β-ALA -L -L-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 63 | FMOC-D-CIT-D-CIT-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 64 | FMOC-β-ALA-D-CIT-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 65 | FMOC-β-ALA-DAB-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 66 | Fmoc- (3 (2-naphthyl) -d-ala) 2-o | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 67 | FMOC-β-ALA-3- (2-Naphthyl) -D-ALA-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 68 | Fmoc- (3 (3-pyridinyl) -d-ala) 2-o | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 69 | FMOC-β-ALA-3- (3-Pyridinyl) -D-ALA-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 70 | FMOC- (4-chloro-D-phe) 2-o | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 71 | FMOC-β-ALA-4-Chloro-D-PH-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 72 | FMOC- (D-4APH (TBUCBM) 2-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 73 | FMOC-β-ALA-D-4APH (TBUCBM) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 74 | FMOC-APH (L-Hor) -APH (L-Hor) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 75 | FMOC-β-ALA-APH (L-Hor) -Oo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 76 | FMOC-LYS (IPR, Boc) -lys (IPR, Boc) -Oo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 77 | FMOC-β-ALA-LYS (IPR, Boc) -Oo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 78 | FMOC-β-ALA-AEEA-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 79 | FMOC-AIB-AIB-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 80 | FMOC-β-ALA-AIB-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 81 | FMOC-ArG-OH | 91000-69-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 82 | H-Arg (PBF) -Oo | 200115-86-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 83 | FMOC-D-Arg-oh | 130752-32-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 84 | HD-Arg (PBF) -Oo | 200116-81-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 85 | Neamai, homoarg-oh.hcl | 208174-5-5-5-5-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 86 | H-HOMARG (PBF) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 87 | Fmoc-d-homoarg-o | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 88 | HD-Homoarg (PBF) -Oo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 89 | FMOC-ASN-OH | 71989-16-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 90 | H -ASN (TT) -OOH | 132388-58-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 91 | FMOC-ASP-OH | 119062-05-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 92 | H-asp (otbu) -oh | 3057-74-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 93 | FMOC-CIY-OH | 135248-89-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 94 | H-CYS (TT) -OOH | 2799/7/7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 95 | H-CYS (ACM) -OH.HCL | 28798-28-9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 96 | FMOC-GLN-OH | 71989-20-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 97 | H-GLN (TT) -OOH | 102747-84-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 98 | FMOC-Glu-oh | 12134332-82-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 99 | H-GLLU (OTBU.H.H2O | 2419-66-9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 100 | FMOC-HER-OH | 116611-64 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 101 | H-yake (trt) -Oo | 35146-32-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 102 | Boc-yake-oh | 17791-525 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 103 | FMOC-LYS-OH | 105047-45-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 104 | H-LYS (Boc) -Oo | 2418-95-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 105 | H-LYS (Alloc) -Oo | 6298/3/3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 106 | Nefsvamusic-oah.hcl | 201046-57-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 107 | H-Orn (Boc) -Oo | 13650-49-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 108 | FMOC-Ser-OH | 73724-45-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 109 | H-SE (TBU) -OOH | 18822-58-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 110 | H-SE (TT) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 111 | FMOC-AD-OH.H2O | 73731-37-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 112 | H-th (tbu) -oh | 4378-13-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 113 | FMOC-TRP-OH | 35737-15-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 114 | H-TP (Boc) -Oo | 146645-63-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 115 | FMOC-D-TRP-OH | 86123-11-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 116 | HD-TRP (Boc) -Oo | 201290-11-11-1 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 117 | FMOC-TYR-OH | 92954-90-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 118 | H-TYR (TBU) -OOH | 18822-59- | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 119 | FMOC-D-TYR-OH | 11288-29-1 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 120 | Hd-tyr (et) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 121 | H-tyr (ini) -oh.hcl | 67423-44-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 122 | FMOC-D-4APH (CBM) -OOH | 324017-22-3-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 123 | HD-4APH (TBUCBM) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 124 | FMOC-LYS (IPR) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 125 | H-LYS (IPR, Boc) -Oo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
Nezve
Muripo
Eltiyox inopa yakakura mhando zvigadzirwa, kana chero zvigadzirwa zvechigadzirwa zvichimutswa nemutengi mukati mezvipupurudzo zvakaringana, isu tichapa kuongororwa kwakakodzera uye kuongororwa kuti tidzorere maitiro emuripo.
Kugadzirwa
Maitiro ezvigadzirwa zvechechi akasvika tens
Tsvagurudzo uye Kubudirira
Gore roga roga, pane zano rakamiswa neR & D timu yekuvandudza zvigadzirwa zvitsva zvakasiyana, kana zvinangwa zvevakasarudzika, nhengo yega yega muchikwata ichazoenda nayo neKPI mutoro uye neyakafarira mutemo.
